Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Addex Therapeutics
(NASDAQ:ADXN)
Intraday
$17.00
-1.74
[-9.28%]
After-Hours
$17.00
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$17.00
-1.74
[-9.28%]
At close: Apr 24
$17.00
0
[0.00%]
After Hours: 9:10AM EDT
Get Report
Watch
Q4 2023 Earnings were released on Thu Apr 18th, before the market open
The most recent conference call was at 10:00 AM, 6 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Addex Therapeutics Stock (NASDAQ:ADXN)
Addex Therapeutics Stock (NASDAQ: ADXN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
8 hours ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
12 hours ago
Thursday, April 18, 2024
Earnings Scheduled For April 18, 2024
Benzinga Insights
-
6 days ago
Addex Therapeutics FY23 EPS CHF (0.14) Up From CHF (0.46) YoY, Income CHF 1.65M Up From CHF 1.45M YoY
Benzinga Newsdesk
-
6 days ago
Tuesday, April 16, 2024
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Apr 16, 2024, 2:17PM
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 16, 2024, 8:14AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Apr 16, 2024, 8:07AM
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Apr 10, 2024, 8:09AM
Tuesday, April 09, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Apr 9, 2024, 12:31PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Apr 9, 2024, 8:09AM
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 9, 2024, 6:05AM
Thursday, April 04, 2024
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Apr 4, 2024, 1:21PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Apr 4, 2024, 8:09AM
Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 4, 2024, 7:58AM
Wednesday, April 03, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 3, 2024, 1:56PM
Addex Therapeutics shares are trading higher after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix.
Benzinga Newsdesk
-
Apr 3, 2024, 7:14AM
Addex And Perceptive Launch Neurosterix With $63M To Accelerate Development Of Allosteric Modulator Therapeutics For Neurological Disorders
Benzinga Newsdesk
-
Apr 3, 2024, 1:36AM
Tuesday, January 30, 2024
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 30, 2024, 1:18PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 30, 2024, 12:31PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 30, 2024, 8:05AM
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Jan 30, 2024, 7:52AM
Monday, January 08, 2024
Addex Therapeutics Rising On Low Volume Premarket; Company Is Presenting Monday At Biotech Showcase
Charles Gross
-
Jan 8, 2024, 5:32AM
Wednesday, November 29, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Nov 29, 2023, 4:31PM
Earnings Scheduled For November 29, 2023
Benzinga Insights
-
Nov 29, 2023, 7:46AM
Addex Therapeutics Filed For Offering Of Up To 516,081 ADSs Representing 61,929,720 Shares
Charles Gross
-
Nov 29, 2023, 6:50AM
Addex Therapeutics Q3 Sales $370.87K Down From $430.68K YoY; Net Loss $2.96M Versus $4.65M YoY
Benzinga Newsdesk
-
Nov 29, 2023, 1:19AM
Tuesday, November 14, 2023
Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment Of Patients; Top Line Results Expected In 2Q24
Benzinga Newsdesk
-
Nov 14, 2023, 1:54AM
Monday, November 13, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Nov 13, 2023, 8:06AM
Wednesday, November 08, 2023
Addex Therapeutics Regains Compliance With NASDAQ's Minimum Bid Price Rule
Benzinga Newsdesk
-
Nov 8, 2023, 3:00AM
Friday, October 20, 2023
Addex Therapeutics Announces 1-for-20 Reverse ADS Split to Regain Nasdaq Compliance
Benzinga Newsdesk
-
Oct 20, 2023, 3:12AM
Monday, October 16, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Oct 16, 2023, 5:31PM
Monday, October 09, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Oct 9, 2023, 1:31PM
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 9, 2023, 1:30PM
Addex Therapeutics shares are trading lower after the company announced its plan to change the ratio of its American Depositary Shares from an ADS ratio of 1 to 6 to an ADS Ratio of 1 to 120
Benzinga Newsdesk
-
Oct 9, 2023, 10:28AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Oct 9, 2023, 9:06AM
Friday, October 06, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Oct 6, 2023, 5:31PM
Addex Announces Plan To Implement ADS Ratio Change; Current ADS Ratio Of 1 ADS To 6 Ordinary Shares To A New ADS Ratio Of 1 ADS To 120 Ordinary Shares
Benzinga Newsdesk
-
Oct 6, 2023, 4:02PM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 4, 2023, 9:06AM
Thursday, September 21, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Sep 21, 2023, 9:06AM
Wednesday, September 20, 2023
Addex Therapeutics Secures €4M Eurostars Grant for mGlu2 NAM Program in Neurocognitive Disorder
Benzinga Newsdesk
-
Sep 20, 2023, 3:17AM
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 19, 2023, 12:50PM
Wednesday, September 06, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Sep 6, 2023, 9:06AM
Tuesday, September 05, 2023
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Sep 5, 2023, 1:34PM
Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Sep 5, 2023, 8:11AM
Addex ADX71149 Phase 2 Epilepsy Study Advances: Cohort 1 Completed, 80% Of Patients Enrolled In Cohort 2; Data Readout Expected In 2Q24
Benzinga Newsdesk
-
Sep 5, 2023, 2:57AM
Addex Therapeutics's Dipraglurant Development In Post-Stroke Recovery Supported By Data Published In Brain
Benzinga Newsdesk
-
Sep 5, 2023, 1:25AM
Thursday, August 10, 2023
Earnings Scheduled For August 10, 2023
Benzinga Insights
-
Aug 10, 2023, 6:59AM
CORRECTION: Addex Therapeutics Q2 EPADS $(0.27) Up From $(1.18) YoY, Sales $702.81K Up From $192.89K YoY
Benzinga Newsdesk
-
Aug 10, 2023, 3:22AM
Addex Therapeutics Q2 EPADS $(0.27) Up From $(1.18) YoY, Sales $702.81K Up From $192.89K YoY
Benzinga Newsdesk
-
Aug 10, 2023, 2:18AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch